0461 1530610
+39 3270618947
prenotazioni@gam-medical.com
Prenota Colloquio Gratuito
Trustpilot
Trustpilot
Trustpilot
Inizia il test ADHD

Pubblicazioni scientifiche del Prof. Andreas Conca

Il Prof. Andreas Conca è medico psichiatra e psicoterapeuta, autore e co-autore di numerose pubblicazioni scientifiche nazionali e internazionali in ambito psichiatrico.

La sua attività di ricerca si concentra in particolare su ADHD e disturbi del neurosviluppo, psicofarmacologia e therapeutic drug monitoring, suicidologia, schizofrenia, neuromodulazione, organizzazione dei servizi di salute mentale e innovazione in psichiatria.

In questa pagina sono raccolte le pubblicazioni scientifiche in cui il Prof. Conca è direttamente coinvolto, organizzate per area tematica per facilitare la consultazione da parte di pazienti, professionisti sanitari, giornalisti e stakeholder scientifici.

Indice delle aree di ricerca

Per approfondire il profilo clinico e istituzionale del medico, consulta anche la pagina dedicata al Prof. Andreas Conca.

Pubblicazioni scientifiche su adhd e neurosviluppo

Le pubblicazioni del Prof. Conca su ADHD e neurosviluppo includono studi clinici, osservazionali e organizzativi sui percorsi di diagnosi e trattamento, sui correlati cognitivi e circadiani del disturbo e sulla transizione tra servizi pediatrici e servizi per adulti.

  1. Roberti E, Clavenna A, Basso E, Scarpellini F, Campi R, Giardino M, Zanetti M, Bonati M; on behalf of the TransiDEA Group. Delphi consensus on the transition from pediatric to adult care in Italian ADHD youth. Eur Child Adolesc Psychiatry. 2025 Dec;34(12):4083-4091. doi:10.1007/s00787-025-02810-w. Epub 2025 Jul 23. PMID: 40699327.
  2. Maniscalco I, Bartochowski P, Priori V, Iancau SP, De Francesco M, Innamorati M, Jagodzinska N, Giupponi G, Masucci L, Conca A, Mroczek M. The effects of fecal microbial transplantation on the symptoms in autism spectrum disorder, gut microbiota and metabolites: a scoping review. Microorganisms. 2025 May 31;13(6):1290. doi:10.3390/microorganisms13061290. PMID: 40572178.
  3. Occhionero M, Tonetti L, Conca A, Giovagnoli S, Giupponi G, Zoppello M, Natale V. Activity-based prospective memory in ADHD during motor sleep inertia. Sensors (Basel). 2023 May 30;23(11):5181. doi:10.3390/s23115181. PMID: 37299910.
  4. Conca A, Raponi A, Gozzi G, Tommasino S, Morsiani A, Rafanelli C, Innamorati M, Holzer S, Florio V, Giupponi G. Adult ADHD: a study on evaluation and treatment pathways in Italian mental health services. Riv Psichiatr. 2021 Nov-Dec;56(6):300-307. doi:10.1708/3713.37043. PMID: 34927624.
  5. Zadra E, Giupponi G, Migliarese G, Oliva F, De Rossi P, Gardellin F, Scocco P, Holzer S, Venturi V, Sale A, Corato AM, Paletta S, Portigliatti Pomeri A, Ferreri P, Busetto P, Palucchini A, De Dominicis F, Florio V, Bizzarri JV, Boschello F, Contardi A, Mari L, Gubbini S, Manzi A, Nicolò G, Manfredi G, Raponi A, Bruletti S, Ravelli L, Steiner V, Danieli A, Reibman Y, Cerveri G, Bondi E, Innamorati M, Perugi G, Pompili M, Mencacci C, Conca A. Survey on centres and procedures for the diagnosis and treatment of adult ADHD in public services in Italy. Riv Psichiatr. 2020 Nov-Dec;55(6):355-365. doi:10.1708/3503.34894. PMID: 33349729.
  6. Tonetti L, Occhionero M, Boreggiani M, Conca A, Dondi P, Elbaz M, Fabbri M, Gauriau C, Giupponi G, Leger D, Martoni M, Rafanelli C, Roncuzzi R, Zoppello M, Natale V. Sleep and prospective memory: a retrospective study in different clinical populations. Int J Environ Res Public Health. 2020 Aug 22;17(17):6113. doi:10.3390/ijerph17176113. PMID: 32842672.
  7. Piacentino D, De Rossi P, Kotzalidis GD, Maniscalco I, Pompili M, Giupponi G, Hiemke C, Conca A. Methylphenidate challenge test in adults with attention deficit/hyperactivity disorder (ADHD): clinical effects and their predictors. Hum Psychopharmacol. 2020 Sep;35(5):e2740. doi:10.1002/hup.2740. PMID: 32785944.
  8. Tessari L, Angriman M, Díaz-Román A, Zhang J, Conca A, Cortese S. Association between exposure to pesticides and ADHD or autism spectrum disorder: a systematic review of the literature. J Atten Disord. 2022 Jan;26(1):48-71. doi:10.1177/1087054720940402. PMID: 32697136.
  9. Giupponi G, Innamorati M, Rogante E, Sarubbi S, Erbuto D, Maniscalco I, Sanna L, Conca A, Lester D, Pompili M. The characteristics of mood polarity, temperament, and suicide risk in adult ADHD. Int J Environ Res Public Health. 2020 Apr 21;17(8):2871. doi:10.3390/ijerph17082871. PMID: 32326351.
  10. Tonetti L, Conca A, Giupponi G, Filardi M, Natale V. Circadian activity rhythm in adult attention-deficit hyperactivity disorder. J Psychiatr Res. 2018 Aug;103:1-4. doi:10.1016/j.jpsychires.2018.05.002. PMID: 29753192.
  11. Giupponi G, Giordano G, Maniscalco I, Erbuto D, Berardelli I, Conca A, Lester D, Girardi P, Pompili M. Suicide risk in attention-deficit/hyperactivity disorder. Psychiatr Danub. 2018 Mar;30(1):2-10. doi:10.24869/psyd.2018.2. PMID: 29546852.
  12. Tonetti L, Conca A, Giupponi G, Natale V. Circadian pattern of motor activity in adults with attention-deficit/hyperactivity disorder. Chronobiol Int. 2017;34(6):802-807. doi:10.1080/07420528.2017.1309660. PMID: 28409677.
  13. Plattner B, Aglan AZ, Juen B, Conca A. [Teachers and attention deficit and/or hyperactivity disorder: a pilot study on the situation of teachers in Tyrol]. Neuropsychiatr. 2013;27(2):74-78. doi:10.1007/s40211-013-0063-9. German. PMID: 23653436.
  14. Schuster I, Schwitzer GO, Hinterhuber H, Bitriol T, Müller M, Plattner B, Conca A. [ADHD in adults: identifying, experiencing, comprehending]. Neuropsychiatr. 2011;25(2):59-66. German. PMID: 21672504.

Pubblicazioni scientifiche su suicidio, stigma e salute pubblica

Una parte rilevante della produzione scientifica del Prof. Conca riguarda la suicidologia, la prevenzione del suicidio, i fattori di rischio clinici e sociali, lo stigma e l’impatto dei servizi di salute mentale nei contesti di vulnerabilità.

  1. Giupponi G, Conca A, Mavrogiorgou P, Juckel G. [Suizide prevention in Italy and Germany: An overview]. Fortschr Neurol Psychiatr. 2026 Feb 13. doi:10.1055/a-2791-7446. Epub ahead of print. German. PMID: 41688045.
  2. Stockner M, Wenter A, Obexer A, Gualtieri I, Merler F, Bennato D, Conca A. Emotional reactions and stigmatization after a parricide in South Tyrol, Italy, among mental health professionals and the general population, including persons with mental disorders, relatives, and persons with no direct or indirect contact. Front Public Health. 2024 Jul 1;12:1388842. doi:10.3389/fpubh.2024.1388842. PMID: 39011331.
  3. Vargiu N, Belfanti A, Roberti M, Trentin S, Ferrara C, Tosti M, Lazzeri M, Giupponi G, Conca A. Empowerment of Italian general practitioners in depression and suicide prevention: the iFightDepression tool, a game changer of the EAAD-Best project. Ann Gen Psychiatry. 2024 Jun 26;23(1):24. doi:10.1186/s12991-024-00506-0. PMID: 38926725.
  4. Stockner M, Plattner B, Innamorati M, Hofer A, Burian I, Fronthaler M, Giupponi G, Huber M, Macina C, Perwanger V, Pycha R, Schaller G, Conca A. How mental health and suicidality changed during the COVID-19 pandemic: a longitudinal study in the general and psychiatric population illustrating risk and protective factors. Behav Sci (Basel). 2024 May 3;14(5):386. doi:10.3390/bs14050386. PMID: 38785877.
  5. Tutzer F, Schurr T, Frajo-Apor B, Pardeller S, Plattner B, Schmit A, Conca A, Fronthaler M, Haring C, Holzner B, Huber M, Marksteiner J, Miller C, Perwanger V, Pycha R, Schmidt M, Sperner-Unterweger B, Hofer A. Relevance of spirituality and perceived social support to mental health of people with pre-existing mental health disorders during the COVID-19 pandemic: a longitudinal investigation. Soc Psychiatry Psychiatr Epidemiol. 2024 Aug;59(8):1437-1448. doi:10.1007/s00127-023-02590-1. Epub 2023 Dec 19. PMID: 38112803.
  6. Boldrini T, Girardi P, Clerici M, Conca A, Creati C, Di Cicilia G, Ducci G, Durbano F, Maci C, Maone A, Nicolò G, Oasi O, Percudani M, Polselli GM, Pompili M, Rossi A, Salcuni S, Tarallo F, Vita A, Lingiardi V; Italian Network for Research on Mental Health during COVID-19 Pandemic. Consequences of the COVID-19 pandemic on admissions to general hospital psychiatric wards in Italy: reduced psychiatric hospitalizations and increased suicidality. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Aug 30;110:110304. doi:10.1016/j.pnpbp.2021.110304. PMID: 33737215.
  7. Solmi M, Granziol U, Danieli A, Frasson A, Meneghetti L, Ferranti R, Zordan M, Salvetti B, Conca A, Salcuni S, Zaninotto L. Predictors of stigma in a sample of mental health professionals: network and moderator analysis on gender, years of experience, personality traits, and levels of burnout. Eur Psychiatry. 2020 Jan 31;63(1):e4. doi:10.1192/j.eurpsy.2019.14. PMID: 32093794.
  8. Stefa-Missagli S, Unterrainer HF, Giupponi G, Holasek SJ, Kapfhammer HP, Conca A, Sarlo M, Erbuto D, Rogante E, Moujaes-Droescher H, Davok K, Berardelli I, Krysinska K, Andriessen K, Lester D, Pompili M. Suicide and personality traits: a multicenter study of Austrian and Italian psychiatric patients and students. Suicide Life Threat Behav. 2020 Feb;50(1):220-232. doi:10.1111/sltb.12579. PMID: 31479172.
  9. Stefa-Missagli S, Unterrainer HF, Giupponi G, Wallner-Liebmann SJ, Kapfhammer HP, Conca A, Sarlo M, Berardelli I, Sarubbi S, Andriessen K, Krysinska K, Erbuto D, Moujaes-Droescher H, Lester D, Davok K, Pompili M. Influence of spiritual dimensions on suicide risk: the role of regional differences. Arch Suicide Res. 2020 Oct-Dec;24(4):534-553. doi:10.1080/13811118.2019.1639571. PMID: 31271348.
  10. Zaninotto L, Rossi G, Danieli A, Frasson A, Meneghetti L, Zordan M, Tito P, Salvetti B, Conca A, Ferranti R, Salcuni S, Solmi M. Exploring the relationships among personality traits, burnout dimensions and stigma in a sample of mental health professionals. Psychiatry Res. 2018 Jun;264:327-333. doi:10.1016/j.psychres.2018.03.076. PMID: 29665563.
  11. Giupponi G, Innamorati M, Baldessarini RJ, De Leo D, de Giovannelli F, Pycha R, Conca A, Girardi P, Pompili M. Factors associated with suicide: case-control study in South Tyrol. Compr Psychiatry. 2018 Jan;80:150-154. doi:10.1016/j.comppsych.2017.09.010. PMID: 29091781.
  12. Giupponi G, Maniscalco I, Mathà S, Ficco C, Pernther G, Sanna L, Pompili M, Kapfhammer HP, Conca A. [Suicide risk in somatoform disorders]. Neuropsychiatr. 2018 Mar;32(1):9-17. doi:10.1007/s40211-017-0248-8. German. PMID: 28940150.
  13. Giupponi G, Conca A, Innamorati M, Forte A, Lester D, Erbuto D, Pycha R, Girardi P, Möller-Leimkühler AM, Pompili M. Differences among South Tyrolean suicides: a psychological autopsy study. Wien Klin Wochenschr. 2016 Feb;128(3-4):125-130. doi:10.1007/s00508-015-0877-5. PMID: 26546354.
  14. Giupponi G, Pycha R, Innamorati M, Lamis DA, Schmidt E, Conca A, Kapfhammer HP, Lester D, Girardi P, Pompili M. The association between suicide and the utilization of mental health services in South Tirol, Italy: a psychological autopsy study. Int J Soc Psychiatry. 2014 Feb;60(1):30-39. doi:10.1177/0020764012461209. PMID: 23079861.
  15. Giupponi G, Conca A, Schmidt E, Hinterhuber H, Pompili M, Pycha R. [Suicide in ethnic and cultural minorities – a research on literature]. Neuropsychiatr. 2011;25(2):93-102. German. PMID: 21672508.
  16. Giupponi G, Bizzarri J, Pycha R, Innamorati M, Lester D, Conca A, Girardi P, Tatarelli R, Pompili M. Socioeconomic risk factors and depressive symptoms in alcohol use disorders among male suicides in South Tirol, Italy. J Addict Dis. 2010 Oct;29(4):466-474. doi:10.1080/10550887.2010.509272. PMID: 20924883.

Pubblicazioni scientifiche su psicofarmacologia e therapeutic drug monitoring

L’attività scientifica del Prof. Conca include numerosi contributi su monitoraggio terapeutico, livelli plasmatici dei farmaci, antipsicotici long-acting, antidepressivi, personalizzazione del trattamento e sicurezza farmacologica.

  1. Kuzo N, Gaspari D, Carpi F, Hiemke C, Paulzen M, Conca A, Schoretsanitis G. Pharmacokinetic correlates of clinical response in a retrospective naturalistic cohort of patients treated with long-acting injectable antipsychotics. Schizophr Res. 2026 Feb;288:38-46. doi:10.1016/j.schres.2025.12.012. Epub 2025 Dec 23. PMID: 41443000.
  2. Ferrea S, Kuzo N, Giupponi G, Messina E, Raponi A, Paulzen M, Hiemke C, Conca A, Schoretsanitis G. SARS-CoV-2 vaccination and plasma levels of psychotropic agents: a prospective cohort study. Expert Opin Drug Metab Toxicol. 2025 Oct;21(10):1213-1218. doi:10.1080/17425255.2025.2575386. Epub 2025 Oct 16. PMID: 41083916.
  3. De Donatis D, Verrastro M, Fanelli G, Fabbri C, Maniscalco I, Hart X, Schoretsanitis G, Mercolini L, Ferri R, Lanuzza B, Serretti A, Conca A, Florio V. Mirtazapine blood levels and antidepressant response. Int J Psychiatry Clin Pract. 2024 Jun;28(2):102-106. doi:10.1080/13651501.2024.2409654. PMID: 39340349.
  4. Hart XM, Gründer G, Ansermot N, Conca A, Corruble E, Crettol S, Cumming P, Frajerman A, Hefner G, Howes O, Jukic MM, Kim E, Kim S, Maniscalco I, Moriguchi S, Müller DJ, Nakajima S, Osugo M, Paulzen M, Ruhe HG, Scherf-Clavel M, Schoretsanitis G, Serretti A, Spina E, Spigset O, Steimer W, Süzen SH, Uchida H, Unterecker S, Vandenberghe F, Verstuyft C, Zernig G, Hiemke C, Eap CB. Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: focus on antipsychotics. World J Biol Psychiatry. 2024 Nov;25(9):451-536. doi:10.1080/15622975.2024.2366235. PMID: 38913780.
  5. Schoretsanitis G, Meyer JM, Conca A, Hiemke C. Personalized switching from oral to long-acting injectable second-generation antipsychotics in schizophrenia treatment using pharmacokinetic considerations. Expert Opin Drug Metab Toxicol. 2023 Apr;19(4):189-202. doi:10.1080/17425255.2023.2220962. PMID: 37259573.
  6. Eichentopf L, Hiemke C, Conca A, Engelmann J, Gerlach M, Havemann-Reinecke U, Hefner G, Florio V, Kuzin M, Lieb K, Reis M, Riemer TG, Serretti A, Schoretsanitis G, Zernig G, Gründer G, Hart XM. Systematic review and meta-analysis on the therapeutic reference range for escitalopram: blood concentrations, clinical effects and serotonin transporter occupancy. Front Psychiatry. 2022 Oct 17;13:972141. doi:10.3389/fpsyt.2022.972141. PMID: 36325531.
  7. Hart XM, Hiemke C, Eichentopf L, Lense XM, Clement HW, Conca A, Faltraco F, Florio V, Grüner J, Havemann-Reinecke U, Molden E, Paulzen M, Schoretsanitis G, Riemer TG, Gründer G. Therapeutic reference range for aripiprazole in schizophrenia revised: a systematic review and metaanalysis. Psychopharmacology (Berl). 2022 Nov;239(11):3377-3391. doi:10.1007/s00213-022-06233-2. PMID: 36195732.
  8. Piacentino D, Bianchi E, De Donatis D, Florio V, Conca A. Therapeutic drug monitoring of antidepressants: an underused but potentially valuable tool in primary care. Front Psychiatry. 2022 Mar 29;13:867840. doi:10.3389/fpsyt.2022.867840. PMID: 35422716.
  9. Schoretsanitis G, Haen E, Piacentino D, Conca A, Endres K, Hiemke C, Gründer G, Paulzen M. Effects of body weight, smoking status, and sex on plasma concentrations of once-monthly paliperidone palmitate. Expert Rev Clin Pharmacol. 2022 Feb;15(2):243-249. doi:10.1080/17512433.2022.2020641. PMID: 34918984.
  10. Cellini L, De Donatis D, Zernig G, De Ronchi D, Giupponi G, Serretti A, Xenia H, Conca A, Florio V. Antidepressant efficacy is correlated with plasma levels: mega-analysis and further evidence. Int Clin Psychopharmacol. 2022 Mar 1;37(2):29-37. doi:10.1097/YIC.0000000000000386. PMID: 34908537.
  11. Cellini L, De Donatis D, Mercolini L, Panariello F, De Ronchi D, Serretti A, Conca A, Gaspari D, Giupponi G, Zernig G, Florio V. Switch to 3-month long-acting injectable paliperidone may decrease plasma levels: a case series. J Clin Psychopharmacol. 2021 Nov-Dec;41(6):694-696. doi:10.1097/JCP.0000000000001461. PMID: 34735103.
  12. Schoretsanitis G, Haen E, Piacentino D, Conca A, Endres K, Carpi F, Hiemke C, Gründer G, Paulzen M. Pharmacokinetic correlates of once-monthly paliperidone palmitate-related adverse drug reactions. Clin Pharmacokinet. 2021 Dec;60(12):1583-1589. doi:10.1007/s40262-021-01044-8. PMID: 34142360.
  13. De Donatis D, Porcelli S, Zernig G, Mercolini L, Giupponi G, Serretti A, Conca A, Florio V. Venlafaxine and O-desmethylvenlafaxine serum levels are positively associated with antidepressant response in elder depressed out-patients. World J Biol Psychiatry. 2022 Mar;23(3):183-190. doi:10.1080/15622975.2021.1938668. PMID: 34096828.
  14. Torresani S, Doimo S, Furlato K, Naika F, Conca A, Lasalvia A. [Continuity of care and therapeutic adherence in young people at psychosis onset: the integrated intervention model of the Psychiatric Service of Bolzano]. Riv Psichiatr. 2021 Jan-Feb;56(2):93-99. doi:10.1708/3594.35767. Italian. PMID: 33899830.
  15. Schoretsanitis G, Haen E, Piacentino D, Conca A, Endres K, Hiemke C, Gründer G, Paulzen M. Clinical response in patients treated with once-monthly paliperidone palmitate: analysis of a therapeutic drug monitoring database. Eur Arch Psychiatry Clin Neurosci. 2021 Dec;271(8):1437-1443. doi:10.1007/s00406-021-01257-9. PMID: 33821323.
  16. De Donatis D, Porcelli S, Serretti A, Gaspari D, Caltagirone SS, Giupponi G, Ferraro M, Conca A, Florio V, Zernig G, Mercolini L. Extremely high-dosage zolpidem poisoning with favorable outcome. J Clin Psychopharmacol. 2021 Mar-Apr;41(2):222-223. doi:10.1097/JCP.0000000000001353. PMID: 33587390.
  17. Schoretsanitis G, Baumann P, Conca A, Dietmaier O, Giupponi G, Gründer G, Hahn M, Hart X, Havemann-Reinecke U, Hefner G, Kuzin M, Mössner R, Piacentino D, Steimer W, Zernig G, Hiemke C. Therapeutic drug monitoring of long-acting injectable antipsychotic drugs. Ther Drug Monit. 2021 Feb 1;43(1):79-102. doi:10.1097/FTD.0000000000000830. PMID: 33196621.
  18. Schoretsanitis G, Haen E, Conca A, Piacentino D, Ridders F, Hiemke C, Gründer G, Paulzen M. Lack of smoking effects on pharmacokinetics of oral paliperidone-analysis of a naturalistic therapeutic drug monitoring sample. Pharmacopsychiatry. 2021 Jan;54(1):31-35. doi:10.1055/a-1221-5293. PMID: 32767297.
  19. Schoretsanitis G, Kane JM, Correll CU, Marder SR, Citrome L, Newcomer JW, Robinson DG, Goff DC, Kelly DL, Freudenreich O, Piacentino D, Paulzen M, Conca A, Zernig G, Haen E, Baumann P, Hiemke C, Gründer G; American Society of Clinical Psychopharmacology; Pharmakopsychiatrie TTDMTFOTAFNU. Blood levels to optimize antipsychotic treatment in clinical practice: a joint consensus statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie. J Clin Psychiatry. 2020 May 19;81(3):19cs13169. doi:10.4088/JCP.19cs13169. PMID: 32433836.
  20. De Donatis D, Porcelli S, Serretti A, Florio V, Volanti C, Maniscalco I, Conca A, Saria A. Serum aripiprazole concentrations prehemodialysis and posthemodialysis in a schizophrenic patient with chronic renal failure: a case report. J Clin Psychopharmacol. 2020 Mar-Apr;40(2):200-202. doi:10.1097/JCP.0000000000001178. PMID: 32134859.
  21. Piacentino D, Kotzalidis GD, Schoretsanitis G, Paulzen M, Haen E, Cappelletti S, Giupponi G, Grözinger M, Conca A. Plasma risperidone-related measures in children and adolescents with oppositional defiant/conduct disorders. Clin Psychopharmacol Neurosci. 2020 Feb 29;18(1):41-48. doi:10.9758/cpn.2020.18.1.41. PMID: 31958904.
  22. Unterecker S, Hefner G, Baumann P, Gründer G, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Haen E, Havemann-Reinecke U, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Mössner R, Müller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia MS, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Waschgler R, Zernig G, Zurek G, Hiemke C. [Erratum to: Therapeutic drug monitoring in neuropsychopharmacology: Summary of the consensus guidelines 2017 of the TDM task force of the AGNP]. Nervenarzt. 2019 Sep;90(9):958-960. doi:10.1007/s00115-019-0766-7. German. PMID: 31309271.
  23. De Donatis D, Florio V, Porcelli S, Saria A, Mercolini L, Serretti A, Conca A. Duloxetine plasma level and antidepressant response. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jun 8;92:127-132. doi:10.1016/j.pnpbp.2019.01.001. PMID: 30611837.
  24. Unterecker S, Hefner G, Baumann P, Gründer G, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Haen E, Havemann-Reinecke U, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Mössner R, Müller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia MS, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Waschgler R, Zernig G, Zurek G, Hiemke C. [Therapeutic drug monitoring in neuropsychopharmacology: Summary of the consensus guidelines 2017 of the TDM task force of the AGNP]. Nervenarzt. 2019 May;90(5):463-471. doi:10.1007/s00115-018-0643-9. German. PMID: 30446893.
  25. Schoretsanitis G, Paulzen M, Unterecker S, Schwarz M, Conca A, Zernig G, Gründer G, Haen E, Baumann P, Bergemann N, Clement HW, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud-Sirot E, Laux G, Messer T, Mössner R, Müller MJ, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Silva Gracia M, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Waschgler R, Zurek G, Hiemke C. TDM in psychiatry and neurology: a comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians. World J Biol Psychiatry. 2018 Apr;19(3):162-174. doi:10.1080/15622975.2018.1439595. PMID: 29493375.
  26. Florio V, Porcelli S, Saria A, Serretti A, Conca A. Escitalopram plasma levels and antidepressant response. Eur Neuropsychopharmacol. 2017 Sep;27(9):940-944. doi:10.1016/j.euroneuro.2017.06.009. PMID: 28648553.
  27. Mercolini L, Mandrioli R, Protti M, Conca A, Albers LJ, Raggi MA. Dried blood spot testing: a novel approach for the therapeutic drug monitoring of ziprasidone-treated patients. Bioanalysis. 2014 Jun;6(11):1487-1495. doi:10.4155/bio.14.3. PMID: 25046049.
  28. Mercolini L, Protti M, Fulgenzi G, Mandrioli R, Ghedini N, Conca A, Raggi MA. A fast and feasible microextraction by packed sorbent (MEPS) procedure for HPLC analysis of the atypical antipsychotic ziprasidone in human plasma. J Pharm Biomed Anal. 2014 Jan;88:467-471. doi:10.1016/j.jpba.2013.09.019. PMID: 24176751.
  29. Hausmann A, Hörtnagl C, Müller M, Waack J, Walpath M, Conca A. [Psychotherapeutic interventions in bipolar disorder: a review]. Neuropsychiatr. 2007;21(2):102-109. German. PMID: 17640496.
  30. Conca A, Waler M, Walpoth M, König P, Hausmann A. A case of delayed galactorrhoea as an adverse event of overlapping haloperidol and clozapine administration. Int J Neuropsychopharmacol. 2005 Jun;8(2):303-305. doi:10.1017/S1461145705005109. PMID: 15850503.
  31. Prapotnik M, Di Pauli J, Vetter Z, König P, Conca A, Waschgler R. Antidepressant-associated mania with escitalopram. Eur Psychiatry. 2004 Nov;19(7):455-456. doi:10.1016/j.eurpsy.2004.06.032. PMID: 15504660.

Pubblicazioni scientifiche su schizofrenia, psicosi e neuroscienze cliniche

Il Prof. Conca ha partecipato a studi su schizofrenia, agency, embodiment, attenzione, trattamenti antipsicotici e continuità di cura nei disturbi psicotici.

  1. Rossetti I, Musco MA, Sacheli LM, Capuzzi E, Clerici M, Caldiroli A, Demartini B, Broglia G, Nisticò V, Florio V, Conca A, Maravita A, Paulesu E, Zapparoli L. Dissecting sense of agency in schizophrenia: a predictive coding perspective. Schizophr Bull. 2026 Jan 16;52(1):sbaf054. doi:10.1093/schbul/sbaf054. PMID: 40476873.
  2. Ronconi L, Florio V, Bronzoni S, Salvetti B, Raponi A, Giupponi G, Conca A, Basso D. Wider and stronger inhibitory ring of the attentional focus in schizophrenia. Brain Sci. 2023 Jan 27;13(2):211. doi:10.3390/brainsci13020211. PMID: 36831754.
  3. Rossetti I, Repossi M, Florio V, Demartini B, Conca A, Gambini O, Maravita A. Sense of body ownership and body agency in schizophrenia. Sci Rep. 2022 Nov 12;12(1):19369. doi:10.1038/s41598-022-23988-y. PMID: 36371507.
  4. Hofer A, Kachel T, Plattner B, Chernova A, Conca A, Fronthaler M, Haring C, Holzner B, Huber M, Marksteiner J, Miller C, Pardeller S, Perwanger V, Pycha R, Schmidt M, Sperner-Unterweger B, Tutzer F, Frajo-Apor B. Mental health in individuals with severe mental disorders during the COVID-19 pandemic: a longitudinal investigation. Schizophrenia (Heidelb). 2022 Mar 8;8(1):17. doi:10.1038/s41537-022-00225-z. PMID: 35260590.
  5. Rossetti I, Romano D, Florio V, Doria S, Nisticò V, Conca A, Mencacci C, Maravita A. Defective embodiment of alien hand uncovers altered sensorimotor integration in schizophrenia. Schizophr Bull. 2020 Feb 26;46(2):294-302. doi:10.1093/schbul/sbz050. PMID: 31150551.
  6. Bizzarri JV, Giupponi G, Maniscalco I, Schroffenegger P, Conca A, Kapfhammer HP. [Parkinson’s disease and psychoses]. Neuropsychiatr. 2015;29(1):1-13. doi:10.1007/s40211-014-0132-8. German. PMID: 25586068.

Pubblicazioni scientifiche su TEC, TMS e neuromodulazione

Una linea di ricerca consolidata del Prof. Conca riguarda la neuromodulazione in psichiatria, con contributi su elettroconvulsivoterapia, stimolazione magnetica transcranica, deep brain stimulation e trattamenti per la depressione resistente.

  1. Wedmann FM, Conca A, Di Gregorio P, Florio V, Toscano M, Giupponi G. Falls at the interface between geriatric and psychiatric patients: a critical review from a psychopharmacological perspective. Riv Psichiatr. 2023 Sep-Oct;58(5):195-204. doi:10.1708/4113.41069. PMID: 37807865.
  2. Wilhelmy S, Brühl AB, Himmighoffen H, Conca A, Grözinger M. Electroconvulsive therapy in Switzerland: a survey on contemporary practice in remembrance of a historical meeting. J ECT. 2023 Sep 1;39(3):197-201. doi:10.1097/YCT.0000000000000910. PMID: 36897195.
  3. Martinotti G, Vita A, Fagiolini A, Maina G, Bertolino A, Dell’Osso B, Siracusano A, Clerici M, Bellomo A, Sani G, d’Andrea G, Chiaie RD, Conca A, Barlati S, Di Lorenzo G, De Fazio P, De Filippis S, Nicolò G, Rosso G, Valchera A, Nucifora D, Di Mauro S, Bassetti R, Martiadis V, Olivola M, Belletti S, Andriola I, Di Nicola M, Pettorruso M, McIntyre RS, di Giannantonio M; REAL-ESK Study Group. Real-world experience of esketamine use to manage treatment-resistant depression: a multicentric study on safety and effectiveness (REAL-ESK study). J Affect Disord. 2022 Dec 15;319:646-654. doi:10.1016/j.jad.2022.09.043. PMID: 36167246.
  4. Bizzarri JV, Piacentino D, Kotzalidis GD, Moser S, Cappelletti S, Weissenberger G, Pompili M, Conca A. Aggression and violence toward healthcare workers in a psychiatric service in Italy: a retrospective questionnaire-based survey. J Nerv Ment Dis. 2020 Apr;208(4):299-305. doi:10.1097/NMD.0000000000001126. PMID: 32221184.
  5. Wilhelmy S, Grözinger M, Groß D, Conca A. Electroconvulsive therapy in Italy-current dissemination of treatment and determining factors of the past. J ECT. 2020 Dec;36(4):253-259. doi:10.1097/YCT.0000000000000672. PMID: 32205733.
  6. Minelli A, Abate M, Zampieri E, Gainelli G, Trabucchi L, Segala M, Sartori R, Gennarelli M, Conca A, Bortolomasi M. Seizure adequacy markers and the prediction of electroconvulsive therapy response. J ECT. 2016 Jun;32(2):88-92. doi:10.1097/YCT.0000000000000274. PMID: 26397151.
  7. Grözinger M, Conca A. Bio-psycho-social aspects of an overall treatment plan. Dtsch Arztebl Int. 2015 Jun 12;112(24):419. doi:10.3238/arztebl.2015.0419b. PMID: 26159220.
  8. Gabriela Nielsen M, Congiu C, Bortolomasi M, Bonvicini C, Bignotti S, Abate M, Milanesi E, Conca A, Cattane N, Tessari E, Gennarelli M, Minelli A. MTHFR: genetic variants, expression analysis and COMT interaction in major depressive disorder. J Affect Disord. 2015 Sep 1;183:179-186. doi:10.1016/j.jad.2015.05.003. PMID: 26021967.
  9. Grözinger M, Smith ES, Conca A. On the significance of electroconvulsive therapy in the treatment of severe mental diseases. Wien Klin Wochenschr. 2015 Apr;127(7-8):297-302. doi:10.1007/s00508-015-0749-z. PMID: 25732919.
  10. Conca A, Di Pauli J, Hinterhuber H, Kapfhammer HP. [Deep brain stimulation: a review on current research]. Neuropsychiatr. 2011;25(1):1-8. German. PMID: 21486538.
  11. Schlaepfer TE, George MS, Mayberg H; WFSBP Task Force on Brain Stimulation. WFSBP guidelines on brain stimulation treatments in psychiatry. World J Biol Psychiatry. 2010 Feb;11(1):2-18. doi:10.3109/15622970903170835. PMID: 20146648.
  12. Di Pauli J, Conca A. Impact of seizure duration in maintenance electroconvulsive therapy. Psychiatry Clin Neurosci. 2009 Dec;63(6):769-771. doi:10.1111/j.1440-1819.2009.02028.x. PMID: 20021631.
  13. Rubner P, Koppi S, Conca A. Frequency of and rationales for the combined use of electroconvulsive therapy and antiepileptic drugs in Austria and the literature. World J Biol Psychiatry. 2009;10(4 Pt 3):836-845. doi:10.1080/15622970902838242. PMID: 19995220.
  14. Koppi S, Steger P, Peschina W, Adami P, Conca A. Repetitive transcranial magnetic stimulation in a patient with atypical Todd’s postepileptic paralysis. Psychiatry Clin Neurosci. 2008 Jun;62(3):368. doi:10.1111/j.1440-1819.2008.01811.x. PMID: 18588605.
  15. Eschweiler GW, Vonthein R, Bode R, Huell M, Conca A, Peters O, Mende-Lechler S, Peters J, Klecha D, Prapotnik M, DiPauli J, Wild B, Plewnia C, Bartels M, Schlotter W. Clinical efficacy and cognitive side effects of bifrontal versus right unilateral electroconvulsive therapy (ECT): a short-term randomised controlled trial in pharmaco-resistant major depression. J Affect Disord. 2007 Aug;101(1-3):149-157. doi:10.1016/j.jad.2006.11.012. PMID: 17196664.
  16. Prapotnik M, Pycha R, Nemes C, König P, Hausmann A, Conca A. [Adverse cognitive effects and ECT]. Wien Med Wochenschr. 2006 Apr;156(7-8):200-208. doi:10.1007/s10354-005-0237-6. German. PMID: 16823537.
  17. Hausmann A, Kramer-Reinstadler K, Lechner-Schoner T, Walpoth M, Rupp CI, Hinterhuber H, Conca A. Can bilateral prefrontal repetitive transcranial magnetic stimulation (rTMS) induce mania? A case report. J Clin Psychiatry. 2004 Nov;65(11):1575-1576. doi:10.4088/JCP.v65n1122a. PMID: 15554775.
  18. Hausmann A, Pascual-Leone A, Kemmler G, Rupp CI, Lechner-Schoner T, Kramer-Reinstadler K, Walpoth M, Mechtcheriakov S, Conca A, Weiss EM. No deterioration of cognitive performance in an aggressive unilateral and bilateral antidepressant rTMS add-on trial. J Clin Psychiatry. 2004 Jun;65(6):772-782. doi:10.4088/JCP.v65n0608. PMID: 15291654.
  19. Conca A, Prapotnik M, Peschina W, König P. Simultaneous pattern of rCBF and rCMRGlu in continuation ECT: case reports. Psychiatry Res. 2003 Nov 30;124(3):191-198. doi:10.1016/S0925-4927(03)00077-5. PMID: 14623070.
  20. Conca A, Di Pauli J, Beraus W, Hausmann A, Peschina W, Schneider H, König P, Hinterhuber H. Combining high and low frequencies in rTMS antidepressive treatment: preliminary results. Hum Psychopharmacol. 2002 Oct;17(7):353-356. doi:10.1002/hup.422. PMID: 12415555.
  21. Conca A, Swoboda E, König P, Koppi S, Beraus W, Künz A, Fritzsche H, Weiss P. Clinical impacts of single transcranial magnetic stimulation (sTMS) as an add-on therapy in severely depressed patients under SSRI treatment. Hum Psychopharmacol. 2000 Aug;15(6):429-438. doi:10.1002/1099-1077(200008)15:6<429::AID-HUP227>3.0.CO;2-3. PMID: 12404305.
  22. Conca A, Peschina W, König P, Fritzsche H, Hausmann A. Effect of chronic repetitive transcranial magnetic stimulation on regional cerebral blood flow and regional cerebral glucose uptake in drug treatment-resistant depressives. A brief report. Neuropsychobiology. 2002;45(1):27-31. doi:10.1159/000048669. PMID: 11803238.

Pubblicazioni scientifiche su servizi di salute mentale, organizzazione e COVID-19

Il Prof. Conca ha contribuito a lavori sull’organizzazione dei servizi psichiatrici, sulla salute mentale di popolazione e dei pazienti psichiatrici durante la pandemia e sui modelli di risposta in contesti sanitari complessi.

  1. Wedmann FM, Albasini F, Davidson R, Mayr A, Conca A. Psychiatry in transition: an assessment in the context of societal change. Ann Gen Psychiatry. 2026 Feb 26. doi:10.1186/s12991-026-00637-6. Epub ahead of print. PMID: 41749268.
  2. Borghesani A, Briani A, Clauser P, Carion E, Conca A. [The role of psychiatry in the Emergency Department: the Psychiatric Fast Track model in the Emergency Department of Bolzano Hospital]. Riv Psichiatr. 2025 Mar-Apr;60(2):78-80. doi:10.1708/4487.44877. Italian. PMID: 40242926.
  3. Schaller G, Pycha R, Conca A, Steinert T. [Mental healthcare in South Tyrol]. Nervenarzt. 2025 Jul;96(4):355-361. doi:10.1007/s00115-024-01755-w. Epub 2024 Oct 4. German. PMID: 39365440.
  4. Schurr T, Frajo-Apor B, Pardeller S, Plattner B, Tutzer F, Schmit A, Conca A, Fronthaler M, Haring C, Holzner B, Huber M, Marksteiner J, Miller C, Perwanger V, Pycha R, Schmidt M, Sperner-Unterweger B, Hofer A. Overcoming times of crisis: unveiling coping strategies and mental health in a transnational general population sample during and after the COVID-19 pandemic. BMC Psychol. 2024 Sep 19;12(1):493. doi:10.1186/s40359-024-02001-3. PMID: 39300578.
  5. Post F, Schurr T, Frajo-Apor B, Tutzer F, Schmit A, Plattner B, Conca A, Fronthaler M, Haring C, Holzner B, Huber M, Marksteiner J, Miller C, Pardeller S, Perwanger V, Pycha R, Schmidt M, Sperner-Unterweger B, Hofer A. The longitudinal course of psychological distress and resilience in patients with serious mental illnesses during the first two years of the COVID-19 pandemic. Psychiatry Res. 2024 Sep;339:116064. doi:10.1016/j.psychres.2024.116064. Epub 2024 Jun 27. PMID: 38981412.
  6. Schmit A, Schurr T, Frajo-Apor B, Pardeller S, Plattner B, Tutzer F, Conca A, Fronthaler M, Haring C, Holzner B, Huber M, Marksteiner J, Miller C, Perwanger V, Pycha R, Schmidt M, Sperner-Unterweger B, Hofer A. Long-term impact of resilience and extraversion on psychological distress during the COVID-19 pandemic: a longitudinal investigation among individuals with and without mental health disorders. Front Psychiatry. 2024 Feb 15;15:1304491. doi:10.3389/fpsyt.2024.1304491. PMID: 38426004.
  7. Wedmann FM, Albasini F, Davidson R, Gahler M, Conca A. [Psychiatric specialty training in light of the intergenerational divide – a brief report from the World Congress of Psychiatry in Vienna]. Nervenarzt. 2024 Mar;95(3):275-278. doi:10.1007/s00115-024-01611-x. Epub 2024 Feb 6. German. PMID: 38319319.
  8. Lommer K, Schurr T, Frajo-Apor B, Plattner B, Chernova A, Conca A, Fronthaler M, Haring C, Holzner B, Macina C, Marksteiner J, Miller C, Pardeller S, Perwanger V, Pycha R, Schmidt M, Sperner-Unterweger B, Tutzer F, Hofer A. Addiction in the time of COVID-19: longitudinal course of substance use, psychological distress, and loneliness among a transnational Tyrolean sample with substance use disorders. Front Psychiatry. 2022 Jul 25;13:918465. doi:10.3389/fpsyt.2022.918465. PMID: 35982932.
  9. Plagg B, Piccoliori G, Engl A, Wiedermann CJ, Mahlknecht A, Barbieri V, Ausserhofer D, Koler P, Tauber S, Lechner M, Lorenz WA, Conca A, Eisendle K. Disaster response in Italian nursing homes: a qualitative study during the COVID-19 pandemic. Geriatrics (Basel). 2022 Mar 17;7(2):32. doi:10.3390/geriatrics7020032. PMID: 35314604.
  10. Plagg B, Flarer H, Conca A, Wiedermann CJ, Engl A, Piccoliori G, Mairhofer S, Barbieri V, Eisendle K. Who is watching the children? A quantitative analysis of strategies for reconciling work and parenting during lockdown in Northern Italy. Int J Environ Res Public Health. 2021 Oct 24;18(21):11174. doi:10.3390/ijerph182111174. PMID: 34769693.
  11. Pycha R, Giupponi G, Schwitzer J, Duffy D, Conca A. Italian psychiatric reform 1978: milestones for Italy and Europe in 2010? Eur Arch Psychiatry Clin Neurosci. 2011 Nov;261 Suppl 2:S135-S139. doi:10.1007/s00406-011-0245-z. PMID: 21909732.
  12. Steinert T, Lepping P, Bernhardsgrütter R, Conca A, Hatling T, Janssen W, Keski-Valkama A, Mayoral F, Whittington R. Incidence of seclusion and restraint in psychiatric hospitals: a literature review and survey of international trends. Soc Psychiatry Psychiatr Epidemiol. 2010 Sep;45(9):889-897. doi:10.1007/s00127-009-0132-3. PMID: 19727530.
  13. Pycha R, Conca A. [Psychiatric care in South Tyrol — an example of coordination]. Wien Med Wochenschr. 2006 Feb;156(3-4):111-117. doi:10.1007/s10354-005-0257-2. German. PMID: 16699942.

Pubblicazioni scientifiche su disturbi dell’umore, depressione e bipolarità

Questa sezione raccoglie contributi su depressione maggiore, disturbo bipolare, biomarcatori, risposta al trattamento e aspetti clinici e psicoterapeutici dei disturbi dell’umore.

  1. Maniscalco I, Toffol E, Giupponi G, Conca A. Erratum zu: Das Zusammenwirken von Rhodiola rosea (Rosenwurz) und Antidepressiva. Neuropsychiatr. 2023 Jun;37(2):107. doi:10.1007/s40211-023-00465-0. German. PMID: 37106312.
  2. Buoli M, Cesana BM, Maina G, Conca A, Fagiolini A, Steardo L Jr, Altamura AC, Dell’Osso B; ISBD Italian Chapter Epidemiologic Group. Correlates of current rapid-cycling bipolar disorder: results from the Italian multicentric RENDiBi study. Eur Psychiatry. 2019 Oct;62:82-89. doi:10.1016/j.eurpsy.2019.09.001. PMID: 31550582.
  3. Maniscalco I, Toffol E, Giupponi G, Conca A. [The interaction of Rhodiola rosea and antidepressants. A case report]. Neuropsychiatr. 2015;29(1):36-38. doi:10.1007/s40211-014-0124-8. German. PMID: 25413939.
  4. Florio V, Savazzi S, Conca A, Marzi CA. Differential impairment of interhemispheric transmission in bipolar disease. Exp Brain Res. 2013 Oct;230(2):175-185. doi:10.1007/s00221-013-3642-x. PMID: 23857169.
  5. Milanesi E, Minelli A, Cattane N, Cattaneo A, Mora C, Barbon A, Mallei A, Popoli M, Florio V, Conca A, Bignotti S, Gennarelli M. ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorder. BMC Psychiatry. 2012 Sep 18;12:145. doi:10.1186/1471-244X-12-145. PMID: 22989054.
  6. Giupponi G, Pycha R, Erfurth A, Hausmann A, Conca A. [Depressive symptoms and the idiopathic Parkinson’s syndrome (IPS): a review]. Neuropsychiatr. 2008;22(2):71-82. German. PMID: 18606109.
  7. Hausmann A, Fuchs M, Walpoth M, Hörtnagl C, Adami P, Conca A. [Are there substantial reasons for contraindicating antidepressants in bipolar disorder? Part III. The alternatives!]. Neuropsychiatr. 2007;21(4):248-260. German. PMID: 18082106.
  8. Conca A, Grohmann R, Di Pauli J, Hausmann A. [Is there a rationale in combining anticonvulsants for bipolar patients?]. Neuropsychiatr. 2007;21(2):159-171. German. PMID: 17640500.
  9. Hausmann A, Hörtnagl C, Walpoth M, Fuchs M, Conca A. [Are there substantial reasons for contraindicating antidepressants in bipolar disorder? Part II: facts or artefacts?]. Neuropsychiatr. 2007;21(2):131-158. German. PMID: 17640499.

Altri contributi clinici e review

Oltre alle principali aree sopra descritte, il Prof. Conca ha contribuito a studi su dipendenze, gerontopsichiatria, Parkinson, etica, cultura medica e altri temi trasversali della pratica clinica e della ricerca.

  1. Wilhelmy S, Giupponi G, Groß D, Eisendle K, Conca A. A shift in psychiatry through AI? Ethical challenges. Ann Gen Psychiatry. 2023 Nov 2;22(1):43. doi:10.1186/s12991-023-00476-9. PMID: 37919759.
  2. Patriarca C, Modena P, Massimino M, Gibilisco F, Barbareschi M, Conca A. Science and pseudo science: racist eugenics in Italy. Pathologica. 2023 Apr;115(2):117-125. doi:10.32074/1591-951X-844. PMID: 36704872.
  3. Bizzarri JV, Casetti V, Sanna L, Maremmani AGI, Rovai L, Bacciardi S, Piacentino D, Conca A, Maremmani I. Erratum to: Agonist opioid treatment as historical comprehensive treatment (‘Dole & Nyswander’ methodology) is associated with better toxicology outcome than Harm Reduction Treatment. Ann Gen Psychiatry. 2017 Feb 13;16:10. doi:10.1186/s12991-017-0132-8. PMID: 28289435.
  4. Bizzarri JV, Casetti V, Sanna L, Maremmani AG, Rovai L, Bacciardi S, Piacentino D, Conca A, Maremmani I. The newer opioid agonist treatment with lower substitutive opiate doses is associated with better toxicology outcome than the older Harm Reduction Treatment. Ann Gen Psychiatry. 2016 Nov 25;15:34. doi:10.1186/s12991-016-0109-z. PMID: 27933094.
  5. Bizzarri JV, Casetti V, Panzani P, Unterhauser J, Mulas S, Fanolla A, Zitelli C, Briani A, Giupponi G, Maremmani I, Conca A. Risky use and misuse of alcohol and cigarettes in psychiatric inpatients: a screening questionnaire study. Compr Psychiatry. 2016 Oct;70:9-16. doi:10.1016/j.comppsych.2016.05.011. PMID: 27624418.
  6. Grözinger M, Conca A. Letter to the editor. World J Biol Psychiatry. 2016 Oct;17(7):562. doi:10.3109/15622975.2013.843787. PMID: 24161230.
  7. Grözinger M, Conca A. [Generation y: problematic consequences for psychiatry and psychotherapy – pro & contra]. Psychiatr Prax. 2013 Mar;40(2):62-63. doi:10.1055/s-0032-1332829. German. PMID: 23459875.
  8. Rehor G, Eiler M, Conca A. [D3 agonism: an augmentative treatment in tardive dyskinesia? A case report]. Psychiatr Prax. 2008 Nov;35(8):404-405. doi:10.1055/s-2008-1067380. German. PMID: 18504692.

Nota editoriale

L’elenco riportato in questa pagina raccoglie le pubblicazioni scientifiche in cui il Prof. Andreas Conca è direttamente coinvolto come autore o co-autore, sulla base del file bibliografico fornito, organizzate per area di ricerca per migliorare la consultazione e la leggibilità della pagina.

Vai alla pagina del Prof. Andreas Conca